HNB
DFTX

Huntington National Bank’s Definium Therapeutics DFTX Stock Holding History

Huntington National Bank’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Hold
1
– – ﹤0.01% 4081
2025
Q4 		$1 Hold
1
– – ﹤0.01% 3988
2025
Q3 		$1 Hold
1
– – ﹤0.01% 4015
2025
Q2 		$1 Hold
1
– – ﹤0.01% 4021
2025
Q1 		$1 Hold
1
– – ﹤0.01% 4035
2024
Q4 		$1 Hold
1
– – ﹤0.01% 4030
2024
Q3 		$1 Hold
1
– – ﹤0.01% 4024
2024
Q2 		$1 Hold
1
– – ﹤0.01% 3973
2024
Q1 		$1 Hold
1
– – ﹤0.01% 3842
2023
Q4 		$1 Hold
1
– – ﹤0.01% 3740
2023
Q3 		$1 Hold
1
– – ﹤0.01% 3711
2023
Q2 		$1 Hold
1
– – ﹤0.01% 3658
2023
Q1 		$1 Hold
1
– – ﹤0.01% 3529
2022
Q4 		$1 Sell
1
-2,000
-100% -$5.55K ﹤0.01% 3396
2022
Q3 		$7K Buy
2,001
+1
+0.1% +$10 ﹤0.01% 1631
2022
Q2 		$19K Hold
2,000
– – ﹤0.01% 1356
2022
Q1 		$33K Hold
2,000
– – ﹤0.01% 1194
2021
Q4 		$41K Sell
2,000
-2,000
-50% -$63.8K ﹤0.01% 1138
2021
Q3 		$140K Hold
4,000
– – ﹤0.01% 679
2021
Q2 		$207K Buy
+4,000
New +$210K ﹤0.01% 614

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Huntington National Bank's DFTX Position: Q1 2026 in Review

Huntington National Bank held its Definium Therapeutics (DFTX) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #4081.

Huntington National Bank first reported a position in DFTX in Q2 2021 and has held it in 20 quarters since. The position peaked at $207K in Q2 2021. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Huntington National Bank held 1 share of Definium Therapeutics worth $1 as of Q1 2026.
  • Huntington National Bank left its Definium Therapeutics share count unchanged in Q1 2026.
  • Definium Therapeutics made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #4081 holding.
  • Huntington National Bank first reported a position in Definium Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Huntington National Bank's Definium Therapeutics position peaked at $207K in Q2 2021.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.